BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10972897)

  • 41. NADPH oxidase.
    Babior BM
    Curr Opin Immunol; 2004 Feb; 16(1):42-7. PubMed ID: 14734109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).
    Jin H; Webster AD; Vihinen M; Sideras P; Vorechovsky I; Hammarstróm L; Bernatowska-Matuszkiewicz E; Smith CI; Bobrow M; Vetrie D
    Hum Mol Genet; 1995 Apr; 4(4):693-700. PubMed ID: 7633420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of Jak3 in lymphoid development, activation, and signaling.
    Thomis DC; Berg LJ
    Curr Opin Immunol; 1997 Aug; 9(4):541-7. PubMed ID: 9287175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular quality control machinery contributes to the leukocyte NADPH oxidase deficiency in chronic granulomatous disease.
    Lin SJ; Huang YF; Chen JY; Heyworth PG; Noack D; Wang JY; Lin CY; Chiang BL; Yang CM; Liu CC; Shieh CC
    Biochim Biophys Acta; 2002 Apr; 1586(3):275-86. PubMed ID: 11997079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease.
    Vihinen M; Vetrie D; Maniar HS; Ochs HD; Zhu Q; Vorechovský I; Webster AD; Notarangelo LD; Nilsson L; Sowadski JM
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12803-7. PubMed ID: 7809124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The search for a genetic defect in Polish patients with chronic granulomatous disease.
    Jurkowska M; Kurenko-Deptuch M; Bal J; Roos D
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):441-6. PubMed ID: 15577746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency.
    Notarangelo LD; Mella P; Jones A; de Saint Basile G; Savoldi G; Cranston T; Vihinen M; Schumacher RF
    Hum Mutat; 2001 Oct; 18(4):255-63. PubMed ID: 11668610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of the flavoprotein domain of gp91phox which has NADPH diaphorase activity.
    Han CH; Nisimoto Y; Lee SH; Kim ET; Lambeth JD
    J Biochem; 2001 Apr; 129(4):513-20. PubMed ID: 11275549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.
    Duriez B; Duquesnoy P; Dastot F; Bougnères P; Amselem S; Goossens M
    FEBS Lett; 1994 Jun; 346(2-3):165-70. PubMed ID: 8013627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A region N-terminal to the tandem SH3 domain of p47phox plays a crucial role in the activation of the phagocyte NADPH oxidase.
    Taura M; Miyano K; Minakami R; Kamakura S; Takeya R; Sumimoto H
    Biochem J; 2009 Apr; 419(2):329-38. PubMed ID: 19090790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
    Schuster V; Seidenspinner S; Kreth HW
    Am J Med Genet; 1996 May; 63(1):318-22. PubMed ID: 8723128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
    Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
    Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hematologically important mutations: X-linked chronic granulomatous disease--an update.
    Heyworth PG; Curnutte JT; Noack D; Cross AR
    Blood Cells Mol Dis; 1997 Dec; 23(3):443-50. PubMed ID: 9454688
    [No Abstract]   [Full Text] [Related]  

  • 54. Atypical X-linked agammaglobulinemia diagnosed in three adults.
    Hashimoto S; Miyawaki T; Futatani T; Kanegane H; Usui K; Nukiwa T; Namiuchi S; Matsushita M; Yamadori T; Suemura M; Kishimoto T; Tsukada S
    Intern Med; 1999 Sep; 38(9):722-5. PubMed ID: 10480303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pleckstrin homology domains of tec family protein kinases.
    Okoh MP; Vihinen M
    Biochem Biophys Res Commun; 1999 Nov; 265(1):151-7. PubMed ID: 10548506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly.
    Li XJ; Fieschi F; Paclet MH; Grunwald D; Campion Y; Gaudin P; Morel F; Stasia MJ
    J Leukoc Biol; 2007 Jan; 81(1):238-49. PubMed ID: 17060362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (BtK).
    Matsushita M; Yamadori T; Kato S; Takemoto Y; Inazawa J; Baba Y; Hashimoto S; Sekine S; Arai S; Kunikata T; Kurimoto M; Kishimoto T; Tsukada S
    Biochem Biophys Res Commun; 1998 Apr; 245(2):337-43. PubMed ID: 9571151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Homologous dinucleotide (GT or TG) deletion in Japanese patients with chronic granulomatous disease with p47-phox deficiency.
    Iwata M; Nunoi H; Yamazaki H; Nakano T; Niwa H; Tsuruta S; Ohga S; Ohmi S; Kanegasaki S; Matsuda I
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1372-7. PubMed ID: 8147881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.
    Gaspar HB; Ferrando M; Caragol I; Hernandez M; Bertran JM; De Gracia X; Lester T; Kinnon C; Ashton E; Espanol T
    Clin Exp Immunol; 2000 May; 120(2):346-50. PubMed ID: 10792386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in X-linked immunodeficiency diseases.
    Ochs HD; Aruffo A
    Curr Opin Pediatr; 1993 Dec; 5(6):684-91. PubMed ID: 7907259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.